News and Opinion
AMR RESEARCH NEWS
- GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic – GW4, June 2021
- GW4 Alliance appoints new permanent director – GW4, June 2021
- Helen Lambert wins a BSAC award to study the implications of COVID-19 for AMR in China and other LMIC settings – Bristol, February 2021
- Scientists identify how harmless gut bacteria “turn bad” – Bath, February 2021
- Scientists pave way to reducing antibiotic resistance build-up in waterways – Exeter, October 2020
READ MORE RESEARCH NEWS FROM:
- THE COVID OUTBREAK AND AMR Dr Phil Mitchelmore, Clinical Lecturer at the University of Exeter, Honorary Consultant at Royal Devon & Exeter Hospital and GW4 Crucible 2020 Alumni reflects on AMR against the backdrop of the COVID crisis, and how GW4 and its Crucible Alumni are set to tackle this global challenge. For the last six months, the coronavirus (COVID-19) pandemic has eclipsed all other concerns, including antimicrobial resistance (AMR). However, while our hopes and expectations are that COVID-19 will be defeated in 2021, it is highly likely that AMR will continue to be the most significant threat to global health and global economy for the coming years.
- ONLINE EVENTS IN THE COVID-ERA: EXPERIENCE FROM THE EARLY CAREER SYMPOSIA SCHEME 2020 Dr Rebecca Weiser (Cardiff University), Dr Hannah Serrage, Dr Gemma Lasseter and Dr Charlie Colenso (University of Bristol) reflect on the challenges they faced delivering the ECR Symposium on ‘Multidisciplinary Approaches to AMR: Bench to Bedside and Beyond’ during a global pandemic, the skills they learnt and the new collaborations developed along the way.
- COVID-19 AND IMPLICATIONS FOR ANTIMICROBIAL RESISTANCE Dr Aimee Murray, Research Fellow at the University of Exeter and GW4 Crucible 2020 Alumni explores how the COVID-19 crisis could impact AMR in clinical and community settings, and explains why GW4 is well placed to research and help combat these significant global challenges.